Community-based Implementation of Adapted STAC
Launched by UNIVERSITY OF WISCONSIN, MADISON · Nov 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the health of Black women and birthing persons, especially regarding issues like high blood pressure during and after pregnancy. The researchers want to adapt a program called Staying Healthy After Childbirth (STAC) to better meet the needs of this community. The goal is to create a supportive approach that helps women and families maintain their health after childbirth.
To participate in the study, you need to be at least 18 years old and identify as African American or Black. If you are pregnant and at least 24 weeks along, or have recently given birth, you could be eligible. Participants will be asked to use a smartphone app called M•other to help manage their health. It's important to note that certain health conditions, like severe heart problems or kidney disease, may prevent someone from joining. The trial is not recruiting participants just yet, but when it does, it aims to gather insights from the community to make healthcare better and more equitable for women and families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria (Interviews and Focus Groups):
- • Belong to the STAC-CAB or Lived Experience Group
- • Aged 18 or older
- Inclusion Criteria (CBO Staff):
- • Staff of CBO participating in PDSA cycle
- • Aged 18 years or older
- Inclusion Criteria (PDSA-Cycles):
- • Pregnant persons greater than or equal to 24 weeks gestation and prior to delivery or postpartum
- • Self-Identify as African American or Black
- • Aged 18 years or older
- • Capable of providing informed consent in English
- • Can follow M•care System use instructions in English
- • Have ownership of a functioning and reliable smartphone to upload and use the M•other App
- Exclusion Criteria (PDSA-Cycles):
- • Persistent second or third trimester bleeding at time of enrollment
- • Premature rupture of membranes in the current pregnancy at time of enrollment
- • Known unrepaired maternal congenital heart disease requiring surgical correction
- • Maternal heart failure
- • Chronic kidney disease specifically requiring dialysis
- • On greater than two antihypertensive medications at time of enrollment
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Kara Hoppe, DO, PhD
Principal Investigator
University of Wisconsin, Madison
Andrew Garbacz, PhD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported